Covington GA & Sacramento CA
UNITED STATES
Fiberboard partition inserts for pharmaceutical and healthcare applications need to meet cleanliness, dimensional precision, and material traceability requirements that go beyond standard packaging specs. The right supplier can provide all of this — often without the high minimums that make customization seem impractical.
Pharmaceutical and healthcare packaging operates under a different set of rules than most industries. The stakes are higher — product that arrives damaged, contaminated, or compromised doesn’t just mean a customer complaint or a returns claim. It means a patient or a clinician without the product they need, and potentially a regulatory reporting obligation.
These requirements don’t make good packaging harder to achieve. They make the specification process more rigorous — and they make the choice of supplier more consequential.
The range of products that need protective inserts within this sector is broad:
What these products have in common: they’re often in glass or high-specification plastic containers, they have zero tolerance for content integrity compromise, and the people receiving them — pharmacists, nurses, surgeons, laboratory technicians — are operating under time pressure in clinical settings.
This is the baseline. A pharmaceutical container that moves within its partition cell during transit is a problem — impact stress on glass, label damage, and potential container compromise. Precision-fit cells, manufactured to tight tolerances, eliminate movement. The relevant dimension is typically within ±1–2mm of the specified cell clearance.
Working with a supplier that maintains documented dimensional tolerances — and can provide inspection data on request — is essential for pharmaceutical applications.
Many pharmaceutical packaging environments have particulate control requirements. The partition material must not shed particles that could contaminate product during packing operations. Solid fiberboard has an advantage here over corrugated board, which can shed paper particles from its fluted interior. The cleaner cut edges and uniform surface of solid fiberboard make it more suitable for controlled or semi-controlled packaging environments.
For Class ISO 7 or 8 (formerly Class 10,000 / 100,000) clean room-adjacent packaging operations, discuss material cleanliness specifications with your supplier.
Pharmaceutical and medical device companies often require documentation of their packaging materials for regulatory dossiers, supplier qualification, and lot traceability. This means:
A supplier that can produce these documents on request — without treating it as an unusual burden — is the right partner for pharmaceutical packaging.
For products where the partition may come into contact with product containers (or where there is a theoretical path for migration of materials), FDA-compliant board grades and inks are required. Request specific documentation from your supplier — not a verbal assurance.
Vial trays. Pharmaceutical vials (2ml, 5ml, 10ml) are typically shipped in cases of 25, 50, or 100 units, each in its own partition cell. Cell dimensions are specified to the nominal vial diameter, with precise clearance specifications. Height is matched to vial height to prevent tipping within the cell.
Ampoule inserts. Ampoules are particularly fragile — thin glass with a sealed tip. The partition cell must eliminate all glass-to-glass contact, and the material choice (polycoated or foam-lined chipboard in direct-contact applications) needs to be specified for the particular glass finish sensitivity.
Pre-filled syringe packaging. Pre-filled syringes in tray configurations use partition or blister-style inserts to maintain orientation and prevent plunger contact. This is often a hybrid system — molded tray for orientation with fiberboard top and bottom pads for shipping.
Medical device packaging. Device components, instruments, and consumables in distribution cases typically use partition inserts that match the device footprint. For sterile device components, the partition is inside the shipping case but outside the sterile barrier — it doesn’t need to be sterile itself, but it must not compromise the sterile barrier through impact or pressure during shipping.
Pharmaceutical and healthcare packaging decisions typically involve more stakeholders than standard packaging — packaging engineering, regulatory affairs, quality assurance, and procurement all have input. The supplier relationship needs to support this.
At Premier Packaging Products, our team is accustomed to working with healthcare and pharmaceutical clients where documentation requirements, approval processes, and quality agreements are part of the engagement. We can provide:
The engagement process may take longer than a standard packaging project — this is appropriate given the stakes, and we support it.
Packaging is a component in pharmaceutical product registration (NDA/ANDA submissions in the US, MAA in Europe). Secondary and tertiary packaging — including inserts — is typically documented in the packaging section of regulatory filings. Changes to validated packaging components may require change control processes and, in some cases, regulatory notification.
For manufacturers with existing validated packaging, any change to partition inserts — material, caliper, supplier — should be evaluated against the change control procedure. “Equivalent” is not sufficient; equivalency must be demonstrated against the validated spec.
For early-stage packaging development (pre-IND, pre-NDA), establishing packaging specifications with flexibility is important — but documenting those specifications formally from early development stages reduces regulatory burden later.
Do pharmaceutical packaging inserts need to be sterile?
Secondary packaging components (inserts in distribution cases, outside sterile barriers) do not generally need to be sterile. However, they must not compromise the sterile barrier — which means they must not generate particles that could penetrate packaging, and must be physically designed to prevent puncture or compression of the primary sterile packaging.
What documentation do I need from a partition insert supplier for pharmaceutical use?
Minimum: material certificate (board grade, caliper, composition), supplier quality agreement, and FDA-compliance statement for the specific board grade. For Class II or Class III device applications, additional documentation may be required. Work with your regulatory affairs team to define the complete documentation set.
Can fiberboard partitions be used in cold chain pharmaceutical shipping?
Yes, with considerations. For refrigerated (2–8°C) storage, standard or coated chipboard performs adequately. For frozen applications, material behavior at sub-zero temperatures should be tested — paper-based materials can become more brittle at very low temperatures. Discuss temperature range requirements with your supplier.
How do I handle a supplier change for a validated pharmaceutical packaging configuration?
A supplier change for a validated packaging component typically requires a formal change control assessment, including comparison testing of the new supplier’s product against the validated spec. Work with your QA team to determine whether the change triggers regulatory notification obligations.
Healthcare packaging doesn’t leave room for “good enough.” The right partition insert — precisely specified, properly documented, and manufactured consistently — is an investment in patient safety and regulatory compliance, not just an operational efficiency measure.
Contact our team to discuss your pharmaceutical or healthcare packaging requirements. We’ll work through the documentation, specifications, and sampling process with you.
Premier Packaging Products — Covington, GA & Sacramento, CA | 770 385 0900